Menu Home » Investor Relations » Goals and Definitions Goals and Definitions Your trusted and focused solution partner since 1923 Share Ticker Elos Medtech B (ELOS B) Latest +/- % Ask Bid 340 5 1.49 335 327 Last update: 24 November 2021, 2:30 This post is also available in: Svenska Overall objectives Build a leading global group in the market for medical devices Strengthen our offering and our expertise Surpass market growth in selected segments Combine organic growth with acquisitions Continuously increase the proportion of our own products and services. Financial targets Achieve long term annual growth in excess of 10 percent for the Group. Achieve long term profitability of an operating margin in excess of 13 percent. Achieve share of own product in excess of 13 percent. Net sales including including acquisitions of 1 000 MSEK Definitions of key performance indicators Term Description Usage Total assets The value of all assets Relevant for enabling stakeholders to easily follow changes in consolidated total assets Yield Dividend in relation to share price at balance sheet date Relevant for providing a measure of the return generated by an equity investment in the form of dividends Equity per share Equity attributable to shareholders parent company’s divided by the number of outstanding shares at the end of the period A measure of the amount of equity that belongs to the shareholders of the parent company Risk-bearing capital The total of the reported amount of equity, any minority interests and deferred tax liability Relevant from a credit point of view, and is one component showing the ability to sustain losses Share of risk-bearing capital Risk-bearing capital as a percentage of total assets Relevant from a credit point of view, shows the ability to sustain losses Liquidity reserve Cash and cash equivalents and undrawn bank overdraft facilities at the end of the period Relevant for assessing the ability to finance future operations as well as variations in the company’s cash flow Net debt Interest-bearing liabilities and interest-bearing provisions (provisions for pensions) less for cash and cash equivalents Relevant for assessing the total interest-bearing debt burden Net sales adjusted for currency translation Changes in net sales adjusted for changes in exchange rates attributable to translation of subsidiaries compared with the same period last year Relevant for assessing the change in net sales compared with previous year Operating capital Total assets as stated in the balance sheet less non-interest-bearing liabilities, non-interest-bearing provisions, interest-bearing non-current receivables and cash and cash equivalents Capital tied up in the business Return on operating capital Operating profit as a percentage of average operating capital Relevant for assessing the return on capital tied up in the business Earnings after tax per share Profit for the period divided by the average number of shares Relevant for enabling investors to assess the return on and the valuation of the shares Operating profit (EBIT) Operating profit before tax and financial items Relevant as a measure of the results of the company’s operating activities Operating margin (EBIT %) Operating profit as a percentage of net sales Relevant for assessing the proportion of revenue retained as profit from operating activities. Can also be used for comparisons between companies Operating profit before depreciation and amortization (EBITDA) Operating profit before scheduled depreciation and amortization, and impairment Relevant as a measure of the business’s ability to generate cash flow before tied up working capital and financial activities EBITDA margin Operating profit before scheduled depreciation and amortization, and impairment, as a percentage of net sales for the year Relevant as a measure of the business’s ability to generate cash flow in relation to net sales Debt/equity ratio Net debt divided by equity Relevant for assessing the capital structure, the ratio between equity and debt Equity ratio Equity including any minority interests as a percentage of total assets Relevant as a measure of self-financing, as it shows the proportion of assets financed by equity CALENDAR Feb 24, 2022 Year-end Report 2021 April, 2022 Annual Report 2021 April 26, 2022 Interim Report Q1, 2022 May 3, 2022 Annual General Meeting 2022 Aug 18, 2022 Interim Report Q2, 2022 Oct 21, 2022 Interim Report Q3, 2022 Feb 23, 2023 Year-end Report 2022 PRESS RELEASES & REGULATORY INFORMATION PRESS RELEASES & REGULATORY INFORMATION Elos Medtech Interim Report January 1 - September 30, 2021 20 Oct 2021, 08:00 Financial / IR information STAY UPDATED! Subscribe to our newsletter SUBSCRIBE Copyright © 2021 by Elos Medtech AB. All rights reserved. Cookies & Privacy Policy Follow us: This website uses cookies to provide you with the best browsing experience. Find out more or adjust your settings. Accept